AMAD, an emodin azide methyl anthraquinone derivative, was extracted from the nature giant knotweed rhizome of traditional Chinese herbs. Here, we investigated the anticancer activities and signaling pathways implicated in AMAD-induced apoptosis in human breast cancer cell lines MDA-MB-453 and human lung adenocarcinoma Calu-3 cells. AMAD was found to have a potent cytotoxic effect on both cell lines. Hoechst 33258 staining and Annexin V/propidium iodide double staining exhibited the typical nuclear features of apoptosis and increased the proportion of apoptotic Annexin V -positive cells in a dose-dependent manner, respectively. Moreover, this apoptotic induction was associated with a collapse of the mitochondrial membrane potential and activated caspases (cysteine aspartase) cascade involving in caspase-8, caspase-9, caspase-3, and poly(ADP-ribose) polymerase cleavage in a concentration-dependent manner. It was noteworthy that AMAD also effectively cleaved Bid, a BH3 domaincontaining proapoptotic Bcl-2 family member, and induced the subsequent release of cytochrome c from mitochondria into the cytosol. Furthermore, suppression of caspase-8 activity with Z
Introduction
Apoptosis is a highly regulated and organized death process controlling the development and homeostasis of multicellular organisms. It is characterized by several well-defined processes including the decrease in cell volume, compaction of cytoplasmic organelles, condensation and fragmentation of nuclear chromatin, internucleosomal DNA cleavage, membrane blebbing, and activation of a family of cysteinyl aspartate-specific proteinases called caspase (1, 2) . Two major pathways of apoptosis depending on different apoptotic stimuli are death receptor pathway (extrinsic) and mitochondrial pathway (intrinsic). In the extrinsic pathway, stimulation of death receptors such as Fas and tumor necrosis factor receptor 1 leads to clustering and formation of a death-inducing signaling complex, which includes the adapter protein, Fas-associated death domain, and initiator caspases such as caspase-8. Caspase-8 drives its activation through selfcleavage and then activates downstream caspases such as caspase-9 and caspase-3 (3). In the intrinsic pathway, death receptors transmit the death signals to mitochondria, resulting in the release of several mitochondrial intermembrane space proteins, such as cytochrome c, which associate with Apaf-1 and procaspase-9 to form the apoptosome (4) .
The mitochondrial pathway is controlled and regulated by the Bcl-2 family proteins. The antiapoptotic subfamily comprises Bcl-2 and Bcl-xl. The multidomain proapoptotic subfamily consists of Bax and Bak and the BH3 domain-only proteins include Bid, Bad, and Bim (5) . Proapoptotic and antiapoptotic Bcl-2 family members converge on mitochondria in response to the death signal and compete to regulate the release of cytochrome c (4). Bid, a BH3-only molecule of the Bcl-2 family, links death receptor signaling to the activation of apoptotic mechanisms in mitochondria. Death receptor -activated caspase-8 cleaves the Bid, which generates a truncated Bid fragment that collaborates with other proapoptotic proteins, such as Bax and Bak to promote the release of mitochondrial factors necessary for activation of executioner caspases and apoptosis.
Anthraquinones represent a large family of compounds having diverse biological properties. Emodin (1,3,8-trihydroxy-6-methylanthraquinone) is a naturally occurring anthraquinone present in the roots and barks of numerous plants, molds, and lichens and an active ingredient of various Chinese herbs including Rheum officinale and Polygonam cuspidatum (6) . Pharmacologic studies using crude as well as pure forms of emodin have been carried out so far and have indicated the role of emodin as purgative, antibacterial, immunosuppressive, vasorelaxant, cardiotonic, and hepatoprotective in nature (7, 8) . Recent studies clearly revealed the specific activity of emodin in oncogene-stimulated cells of different origins as well as its utility of being used as a sensitizor of antitumor drug therapy (9 -12) . Additionally, because of its quinone structure, emodin may interfere with electron transport process and in altering cellular redox status, which may account for its cytotoxic properties in different systems.
We have reported the separation and structure identification of emodin azide methyl anthraquinone derivative (AMAD) as a new compound with a purity of >98%. It was obtained from modified structure of emodin extracted from the nature giant knotweed rhizome of traditional Chinese herbs. In this study, we deciphered the pathway of cell apoptosis induced by emodin AMAD and related molecular mechanisms.
Materials and Methods
Chemicals and Reagents 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), 2 ¶,7 ¶-dichlorofluorescin diacetate, 3,3 ¶-dihexyloxacarbocyanine iodide, and Hoechst 33258 were purchased from Sigma. Adriamycin was from ZhuHai MingZhi Pharmaceuticals. A selective inhibitor of caspase-8 (Z-IETD-FMK) and a caspase-9 inhibitor (Z-LETD-FMK) were purchased from R&D Systems. As a gift, pEGFPC2-H1-MDR1shDNA plasmid was obtained from Dr. Zhi Shi (Sun Yat-sen University). ApopNexin FITC Apoptosis Detection Kit was purchased from Chemicon. Antibodies against caspase-3, caspase-8, caspase-9, poly(ADP-ribose) polymerase (PARP), cytochrome c, Bcl-xl, and Bad were obtained from Cell Signaling Technology. Antibodies against Bax were purchased from Santa Cruz Biotechnology. Antibodies against glyceraldehyde-3-phosphate dehydrogenase, anti-mouse IgG-horseradish peroxidase, and anti-rabbit IgG-horseradish peroxidase were purchased from KangChen Biotechnology. All tissue culture supplies were purchased from Life Technologies. Other routine laboratory reagents were obtained from Whiga Biotechnology of analytical or high-performance liquid chromatography grade. Emodin AMAD with a purity of >98% was obtained from modified structure of emodin extracted from the nature giant knotweed rhizome of traditional Chinese herbs (Fig. 1B) .
Cell Lines and Cell Culture Human breast cancer cell lines MDA-MB-453, human lung adenocarcinoma Calu-3 cells, and normal mouse fibroblast NIH3T3 cell lines obtained from Cell Bank of Chinese Academy of Medical Sciences were grown in DMEM, MEM/nonessential amino acid, and RPMI 1640, respectively, which contain 100 units/mL penicillin, 100 Ag/mL streptomycin, and 10% fetal bovine serum. All cells were cultured in a humidified atmosphere incubator of 5% CO 2 and 95% air at 37jC.
Cell Viability Assay Cells were harvested during logarithmic growth phase and seeded in 96-well plates at a density of 3.5 Â 10 4 /mL in a final volume of 190 AL/well. After 24 h incubation, 10 AL AMAD full-range concentration was added to 96-well plates. After 68 h treatment, 10 AL MTT (10 mg/mL stock solution of saline) was added to each well for 4 h. Subsequently, the supernatant was removed, and MTT crystals were solubilized with 100 AL anhydrous DMSO each well. Thereafter, cell viability was measured by model 550 microplate reader (Bio-Rad) at 540 nm, with 655 nm as reference filter (13) . The 50% inhibitory concentration (IC 50 ) was determined as the anticancer drug concentration causing 50% reduction in cell viability and calculated from the cytotoxicity curves (Bliss' software). Cell percent survival was calculated using the following formula: survival (%) = [(mean experimental absorbance) / (mean control absorbance)] Â 100%.
Assessment of Apoptosis Morphology by Hoechst 33258 Staining
After treatment with or without 2.30 to 9.20 Amol/L AMAD for MDA-MB-453 and 0.75 to 3 Amol/L AMAD for Calu-3, both floating and trypsinized adherent cells were collected, washed once with ice-cold PBS, fixed with 1 mL of 4% paraformaldehyde for 20 min, and washed once with ice-cold PBS. Then, the cells were incubated in 1 mL PBS containing 10 Amol/L Hoechst 33258 at 37jC for 30 min, washed twice, and observed using fluorescence microscopy with standard excitation filters (Leica Dmirb) in random microscopic fields at Â400 magnification (14) .
Annexin V/Propidium Iodide Double-Staining Assay Annexin V and propidium iodide (PI) staining was done using ApopNexin FITC Apoptosis Detection Kit. Cells (6 Â 10 5 ) were seeded in 25 cm 2 flasks and allowed to attach for 24 h. After treated with the desired concentration AMAD for 48 h, both floating and attached cells were collected, washed with ice-cold PBS twice, and resuspended in 200 AL of 1Â binding buffer containing Annexin V (1:50 according to the manufacturer's instruction) and 40 ng/sample PI for 15 min at 37jC in the dark (15) . Then, the number of viable, apoptotic, and necrotic cells was quantified by flow cytometer (Becton Dickinson) and analyzed by the CellQuest software. Cells were excited at 488 nm and the emissions of Annexin V at 525 nm and PI were collected through 610 nm band-pass filters. At least 10,000 cells were analyzed for each sample. Percent apoptosis (%) = [(number of apoptotic cells) / (number of total cells observed)] Â 100%.
DNA-Binding Assay
Being able to intercalate between nucleic bases, epirubicin was used as a positive control of DNA-binding assay (16) . Briefly, 9 to 300 Amol/L AMAD or 5 to 160 Amol/L epirubicin was incubated with pEGFPC2-H1-MDR1shDNA at 37jC for 48 h; 150 Amol/L AMAD or 80 Amol/L epirubicin was incubated with pEGFPC2-H1-MDR1shDNA at 37jC for 1 to 48 h. Then, the mixture was electrophoresed on 1.2% agarose gel stained with 1.5 Amol/L EB at 60 V for 40 min in 0.5Â TBE buffer [44.5 mmol/L Tris-boric acid and 1 mmol/L EDTA (pH 8.3)]. Analyses and photography were done with the gel imaging and analysis system (Vilber Lourmat; ref. 17) .
Determination of Mitochondrial Membrane Potential
Mitochondrial membrane potential (DC m ) was measured by flow cytometry with the mitochondrial tracking fluorescent dye 3,3 ¶-dihexyloxacarbocyanine iodide. The cationic lipophilic fluorochrome 3,3 ¶-dihexyloxacarbocyanine iodide is a cell-permeable marker that specifically accumulates into mitochondrion depending on DC m . After MDA-MB-453 and Calu-3 cells were exposed to 2.30 to 9.20 and 0.75 to 3 Amol/L AMAD for 48 h, respectively, 6 Â 10 5 cells were harvested, centrifuged at 1,000 rpm for 5 min, and washed with ice-cold PBS once. Thereafter, cells were incubated with 40 nmol/L 3,3 ¶-dihexyloxacarbocyanine iodide at 37jC for 20 min in the dark. Then, the cells were washed twice, resuspended in 1 mL PBS, and analyzed by FACS Calibur flow cytometer with the excitation wavelength of 484 nm and emission wavelength of 501 nm (16) . At least 10,000 cells were determined for each sample. The data obtained from flow cytometry were analyzed by CellQuest software and expressed as mean fluorescence intensity. The expressed data were the results of at least three independent determinations.
Measurement of Reactive Oxygen Species Generation 2 ¶,7 ¶-Dichlorofluorescin diacetate is a fluorogenic freely permeable tracer specific for reactive oxygen species (ROS) assessment. It can be deacetylated by intracellular esterase to the nonfluorescent 2 ¶,7 ¶-dichlorofluorescin, which is oxidized by ROS to the fluorescent compound 2 ¶,7 ¶-dichloroflorescein. Thus, the fluorescence intensity of 2 ¶,7 ¶-dichloroflorescein is proportional to the amount of ROS produced by the cells. After MDA-MB-453 and Calu-3 cells were exposed to 2.30 to 9.20 and 0.75 to 3 Amol/L AMAD for 48 h, respectively, 6 Â 10 5 cells were harvested, washed once with ice-cold PBS, and incubated with 50 Amol/L 2 ¶,7 ¶-dichlorofluorescin diacetate at 37jC for 20 min in the dark. Then, the cells were washed twice and maintained in 1 mL PBS. The ROS generation was assessed from 10,000 cells each sample by FACS Calibur flow cytometer at the excitation wavelength of 488 nm and emission wavelength of 530 nm (18) . The data of 2 ¶,7 ¶-dichloroflorescein fluorescence intensity were evaluated by CellQuest software and expressed as mean fluorescence intensity. The experiment was done at least triplicate determination.
Whole-Cell Lysates and Western Blot Analysis After MDA-MB-453 and Calu-3 cells were exposed to 2.30 to 9.20 and 0.75 to 3 Amol/L AMAD for 48 h, respectively [preincubated with Z-IETD-FMK (a caspase-8 inhibitor) or Z-LETD-FMK (a caspase-9 inhibitor)], whole cells were harvested and washed twice with ice-cold PBS, and the pellet was vortexed and 1Â lysis buffer [50 mmol/L TrisHCl (pH 6.8), 10% glycerol, 2% SDS, 0.25% bromophenol blue, and 0.1 mol/L DTT] was added for 100 AL/5 Â 10 6 cells. After heated at 95jC for 20 min, the lysates were centrifuged at 12,000 rpm for 10 min and the supernatant was collected (19) . The protein concentration was determined by nucleic acid-protein analyzer (Beckman). Equal amount of lysate protein was separated on 8% to 12% SDS-PAGE and transferred onto polyvinylidene difluoride membrane (Pall). The nonspecific binding sites were blocked with TBST buffer [150 mmol/L NaCl, 20 mmol/L Tris-HCl (pH 7.4), and 0.4% (v/v) Tween 20] containing 5% nonfat dry milk for 2 h. The membranes were incubated overnight at 4jC with specific primary antibodies. Then, the membranes were washed three times with TBST buffer and incubated at room temperature for 1 h with horseradish peroxidaseconjugated secondary antibody. After three washes with TBST buffer, the immunoblots were visualized by the enhanced Phototope-Horseradish Peroxidase Detection Kit purchased from Cell Signaling Technology and exposed to Kodak medical X-ray processor (18) .
Subcellular Fractionation for Western Blot Analysis of Cytosolic Cytochrome c
After MDA-MB-453 and Calu-3 cells were exposed to 2.30 to 9. bottom left quadrant, cells negative for both Annexin V and PI. C, percent apoptosis. Early apoptotic cell population with Annexin V -positive but PInegative cells increased gradually from 6.1% to 46.3% and from 10.7% to 35.1% in MDA-MB-453 and Calu-3 cells, respectively. However, AMAD had no obvious apoptosis-inducing effect on normal mouse fibroblast NIH3T3 cells even at the concentration of 100 Amol/L. Mean F SD of three assays. *, P < 0.05; **, P < 0.01 versus control.
40 min at 4jC. Then, the cells were centrifuged at 1,200 rpm for 10 min at 4jC; the supernatant was subsequently centrifuged at 12,000 rpm for 15 min at 4jC and the final supernatant was used as cytosolic fraction of cytochrome c. Then, 5Â loading buffer [250 mmol/L Tris-HCl (pH 6.8), 50% (v/v) glycerol, 10% (w/v) SDS, 0.5% (w/v) bromphenol blue, and 5% (w/v) DTT] was added to the above obtained supernatant and the mixture was boiled at 100jC for 15 min. Thus, the protein solution was used for identification of cytosolic cytochrome c by Western blot with 15% SDS-PAGE and blotting onto polyvinylidene difluoride membrane. The cytochrome c protein was detected by using anticytochrome c antibody in the ratio of 1:1,000 (20) .
Statistical Analysis
Results were done by t test or one-way ANOVA with SPSS 13.0 software. Data were presented as mean F SD of at least triplicate determinations. *, P < 0.05 was indicative of significant difference and **, P < 0.01 was indicative of very significant difference.
Results

AMAD Exerted Potent Cytotoxicity against MDA-MB-453 and Calu-3 Cells
MTT assay measures the activity of mitochondrial dehydrogenase enzymes basing on its ability of cleaving tetrazolium ring to produce formazan; thus, the assay can be used as an index of cell viability. The cytotoxicity of AMAD to MDA-MB-453 and Calu-3 cells was measured by MTT assay. AMAD inhibited cell proliferation in a concentration-dependent manner in both MDA-MB-453 and Calu-3 cells after 72 h treatment (Fig. 1C) . The IC 50 of AMAD was 9.06 F 0.95 Amol/L for MDA-MB-453 cells and 0.83 F 0.21 Amol/L for Calu-3 cells, whereas for normal mouse fibroblast NIH3T3 cells was >100 Amol/L (Fig. 1D) . The data suggested that AMAD exhibited potent cytotoxicity against MDA-MB-453 and Calu-3 cells but had little cytotoxicity to normal mouse fibroblast NIH3T3 cells.
AMAD Induced Apoptosis in MDA-MB-453 and Calu-3 Cells
To observe the morphologic characteristics of apoptosis, cells were stained with Hoechst 33258 after MDA-MB-453 and Calu-3 cells were exposed to 2.30 to 9.20 and 0.75 to 3 Amol/L AMAD for 48 h, respectively, and detected by the fluorescence microscopy. Control cells showed even distribution of the stain and round homogeneous nuclei feature. Apoptotic cells increased gradually in a dose-dependent manner and displayed typical changes including reduction of cellular volume, staining bright and condensed or fragmented nucleus (Fig. 2A) . For a further assessment of apoptosis induced by AMAD, we examined the exposure of phosphatidylserine on the cell surface by using Annexin V/PI double staining. Flow cytometric analysis revealed that the percentage of apoptotic cells with Annexin Vpositive but PI-negative cells increased gradually with concentration in AMAD-treated cells (Fig. 2B) (Fig. 2C ). However, AMAD had no obvious apoptosis-inducing effect on normal mouse fibroblast NIH3T3 cells even at the concentration of 100 Amol/L (Fig. 2B and C) .
DNA Intercalation Was Not Involved in Apoptosis Induced by AMAD
DNA is the acting target for some anticancer drugs such as Adriamycin, epirubicin, and daunomycin. We carried out the DNA-binding assay to investigate whether apoptosis induced by AMAD was related to intercalating to DNA as described in Materials and Methods. The results showed that epirubicin effectively intercalated to DNA in concentration-dependent manner. Importantly, it could intercalated to DNA after incubation with pEGFPC2-H1-MDR1shDNA at 37jC only for 1 h (Fig. 3) . However, AMAD showed no binding to DNA even to very high concentration for a long time (Fig. 3) . These results indicated that DNA intercalation was not involved in the apoptosis induced by AMAD.
AMAD Induced the Changes of #8 m in MDA-MB-453 and Calu-3 Cells 3,3 ¶-Dihexyloxacarbocyanine iodide was used as a mitochondrion-specific and voltage-dependent dye for determining DC m , the loss of which is regarded as a limiting factor in the apoptotic pathway. To investigate the mechanisms via which AMAD induced apoptosis in MDA-MB-453 and Calu-3 cells, we determined the effect of AMAD on DC m by flow cytometric analysis. After cells were treated with AMAD as described above, the increase of DC m in concentration-dependent manner was observed in both cells ( Fig. 4A and B, top) . The levels of DC m were 122.0 F 0.3%, Figure 3 . AMAD did not intercalate to DNA. After exposure, 9 to 300 Amol/L AMAD or 5 to 160 Amol/L epirubicin were incubated with pEGFPC2-H1-MDR1shDNA at 37jC for 48 h, respectively, and 150 Amol/L AMAD or 80 Amol/L epirubicin were incubated with pEGFPC2-H1-MDR1shDNA at 37jC for 1 to 48 h, respectively, DNA reaction mixtures was electrophoresed on 1.2% agarose gel stained with 1.5 Amol/L EB at 60 V for 40 min in 0.5Â TBE buffer. The DNA bands were visualized under UV light and photographed. The DNA band fluorescence intensity of exposure to epirubicin was lower than the control in a concentration-and time-dependent manner and the DNA band fluorescence intensity of exposure to AMAD was no different from the control whatever concentration or time. Epirubicin was used as a positive control here.
115.6 F 0.2%, and 191.3 F 3.4% of control in MDA-MB-453 cells and 142.7 F 0.4%, 180.2 F 5.8%, and 221.6 F 1.7% of control in Calu-3 cells, respectively ( Fig. 4A and B, bottom) . The data suggested that mitochondrial dysfunction was involved in the apoptosis induced by AMAD.
Decrease of Intracellular ROS Level in MDA-MB-453 and Calu-3 Cells Induced by AMAD
To investigate whether the mitochondrial dysfunction was mediated by increase of ROS generation, we detected intracellular ROS level by flow cytometric method and 2 ¶,7 ¶-dichlorofluorescin diacetate was used as fluorescent probe. After MDA-MB-453 and Calu-3 cells were exposed to 2.30 to 9.20 and 0.75 to 3 Amol/L AMAD for 48 h, respectively, the decrease of ROS in concentration-dependent manner was observed in both cells (Fig. 4C and D, top) . The intracellular ROS levels of control were 68.3 F 0.4%, 20.4 F 1.6%, and 25.7 F 0.5% in MDA-MB-453 cells and 23.0 F 0.2%, 22.1 F 0.3%, and 15.9 F 0.3% in Calu-3 cells, respectively (Fig. 4C and D, bottom) . The results indicated that mitochondrial dysfunction was independent of more production of ROS.
Release of Cytochrome c and Activation of Caspases Were Involved in the Apoptosis Induced by AMAD
A variety of signaling pathways may be involved in apoptosis and mitochondrial pathway is one of the major apoptosis pathways. Release of cytochrome c from the mitochondria to cytosol is the limiting factor in mitochondrial pathway and the mitochondrial dysfunction has been suggested to cause the release of cytochrome c. Subsequently, it causes apoptosis by activation of caspase-9 in the presence of Apaf-1 and in turn results in the activation of downstream caspase-3, which can cleave PARP (21, 22) . Additionally, Bcl-2 protein family and death receptor pathway are increasingly believed to have relationship with mitochondrial dysfunctions (23) . To elucidate the interactions between the above apoptotic proteins, we detected the cytochrome c in cytosol, caspases, and other apoptotic related proteins of whole-cell lysates by Western blot after MDA-MB-453 and Calu-3 cells were exposed to 2.30 to 9.20 and 0.75 to 3 Amol/L AMAD for 48 h, respectively. The results showed that the release of cytochrome c increased after treatment of AMAD in concentration-corresponding manner (Fig. 5A) . Moreover, the activation of caspase-9 and caspase-3 and the cleavage of PARP in dose-dependent manner were observed. Additionally, AMAD could down-regulate the expression of Bcl-xl and up-regulate the expression of the Bad but did not influence the expression level of Bax. (Fig. 5B) . Furthermore, activation of caspase-8 and cleavage of Bid were observed (Fig. 5C) . These results revealed that death receptor pathway and mitochondrial apoptosis pathway were concomitantly involved in the apoptosis induced by AMAD in MDA-MB-453 and Calu-3 cells and the two pathways could be associated organically by Bid.
Release of Cytochrome c and Bid Cleavage Induced by AMAD Were Inhibited by Z-IETD-FMK rather than Z-LETD-FMK It is increasingly believed that the cleavage form of Bid named as tBid caused by caspase-8 can lead to the release of cytochrome c from mitochondria into cytosol, which subsequently activates caspase-9. We carried out the caspase-8 inhibition experiments to clarify whether the activation of caspase-9 induced by AMAD was the downstream activation of caspase-8. After preincubation with 60 Amol/L Z-IETD-FMK or Z-LETD-FMK for 24 h, MDA-MB-453 or Calu-3 cells were treated with 4.60 or 3 Amol/L AMAD for 48 h, respectively. Then, the wholecell lysates were analyzed by Western blot and corresponding antibodies. The results showed that suppression of caspase-8 activity with Z-IETD-FMK partially inhibited cell apoptosis (Fig. 6A) , release of cytochrome c (Fig. 6B) , and Bid cleavage induced by AMAD (Fig. 6C) , whereas exposure to Z-LETD-FMK, a caspase-9 inhibitor, had no effect. Furthermore, both Z-IETD-FMK and Z-LETD-FMK could reduce PARP cleavage but fail to abolish the effects on other Bcl-2 family members triggered by AMAD, such as Bcl-xl and Bcl-2 (Fig. 6C) .
Discussion
Cancer has become an increasing public health problem for its high rates of morbidity and mortality. In this study, we investigated the anticancer activity of AMAD belonging to emodin AMAD, which was extracted from the nature giant knotweed rhizome of traditional Chinese herbs. Considering that little is known about the anticancer activities and related mechanisms of it, we carried out further investigations to elucidate the antitumor activities of AMAD in human breast cancer cell lines MDA-MB-453 and human lung adenocarcinoma Calu-3 and the possible mechanisms involved.
Our experimental results showed that AMAD displayed potent cytotoxicity to MDA-MB-453 and Calu-3 cells and the IC 50 was 9.06 and 0.83 Amol/L, respectively (Fig. 1C) , whereas the IC 50 of AMAD to normal mouse fibroblast NIH3T3 cells was >100 Amol/L (Fig. 1D) . Apoptosis assay showed that apoptotic cells induced by AMAD displayed condensed and fragmented nuclei by Hoechst 33258 staining ( Fig. 2A) . Annexin V/PI double staining assay further confirmed the results of Hoechst 33258 staining by showing that the important membrane alterations relating to apoptosis in both cells and the percent apoptosis increased in dose-corresponding manner (Fig. 2B and C) . However, AMAD had no obvious apoptosis-inducing effect on normal mouse fibroblast NIH3T3 cells even at the concentration of 100 Amol/L (Fig. 2B and C) . Taken together, these results suggested that AMAD indeed induced apoptosis in MDA-MB-453 and Calu-3 cells but had little cytotoxicity to normal mouse fibroblast NIH3T3 cells.
It has been reported that emodin induce apoptosis in many cells and in response to different stimuli. Proposed mechanisms for the proapoptotic effect include activation of caspases, induction of cytochrome c release, regulation of protein kinase C isoform expression, inhibition of NF-nB, and suppression of AP-1 (24) . Consistent with a previous study, emodin AMAD induced apoptosis in MDA-MB-453 and Calu-3 cells. We carried out more investigations to illuminate the apoptotic pathways involved in the apoptosis induced by AMAD in both cells. Mitochondria has been suggested to play a key role in the regulation of apoptosis. Mitochondrial dysfunctions including loss of DC m , permeability transition, and release of cytochrome c from mitochondria into cytosol are likely to cause apoptosis (25) . In our research, the loss of DC m (Fig. 4A and B) and release of cytochrome c (Fig. 5A) were observed in AMAD-treated MDA-MB-453 and Calu-3 cells. Furthermore, the activation of caspase-8, caspase-9, and caspase-3, the cleavage of PARP, and changes of Bcl-2 family proteins (e.g. Bcl-xl/Bax and Bad) were detected by Western blot (Fig. 5B and C) . Caspase-8 is one major enzyme activating caspase-3. Both TRAIL and tumor necrosis factor-a are known to bind to their cell surface receptors, leading to caspase-8 activation. Activated caspase-8 amplifies the apoptotic signal either by directly activating downstream caspases or by cleaving BH3 domain-only proteins such as Bid (26) . In the current study, suppression of caspase-8 abrogated Bid cleavage, release of cytochrome c into cytosol, and subsequent apoptosis, suggesting that caspase-8 is required for AMAD-induced apoptosis and that the death receptor pathway (extrinsic) may be one possible mechanism for the proapoptotic effects of AMAD (Fig. 6A-C) .
It is increasingly clear that Bid is the molecular linker bridging various death receptor pathways to the central mitochondria pathway (27) . Bid relays the Fas/tumor necrosis factor apoptotic signal to the mitochondrial pathway (28) and is a specific substrate of caspase-8 in the Fas signaling pathway. Once Bid is cleaved by caspase-8, tBid translocates to the mitochondria from the cytosol to induce mitochondrial damage, cell shrinkage, nuclear condensation, and release of cytochrome c. In addition, tBid is able to activate Bax to form Bax multimers in the mitochondria (29) , thereby inducing release of cytochrome c. It is noteworthy that Bid was cleaved after MDA-MB-453 and Calu-3 cells were treated with AMAD, showing decrease of native Bid protein (Fig. 5C) . Furthermore, after treatment with Z-IETD-FMK rather than Z-LETD-FMK, 
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Mol Cancer Ther 2008;7(6). June 2008 tBid formation was completely blocked, suggesting that Bid was the substrate of caspase-8 during apoptosis induced by AMAD in these cells (Fig. 6C) . We also found that both Z-IETD-FMK and Z-LETD-FMK could reduce PARP cleavage but did not restore the changes of other Bcl-2 family members triggered by AMAD, such as Bcl-xl and Bcl-2 (Fig. 6C) . Taken together, our results revealed that both intrinsic and extrinsic pathways took part in AMADinduced apoptosis in two cell lines.
Recent studies have indicated that some anticancer agents (e.g., Adriamycin, epirubicin, and daunomycin) induce apoptosis in part with generation of ROS and the disruption of redox homeostasis (30) . However, our research showed that AMAD suppressed production of ROS in MDA-MB-453 and Calu-3 cells (Fig. 4C and D) . This indicated that apoptosis induced by AMAD was ROS independent. We tried to explain it chemically and biologically by comparing how analogues of AMAD influenced ROS generation. Emodin (or emodin-containing extracts) seems to accomplish an antioxidant status due to different mechanisms such as inhibition of radical formation, radical scavenging, inhibition of lipid peroxidation, and enhancement of antioxidant defenses (31 -38) . It is clear from the above studies that emodin behaves as a protector of cell constituents in presence of an oxidant stress. These findings provide supports for our result that AMAD decreased the ROS levels in MDA-MB-453 and Calu-3 cells. However, recent studies using emodin in cancer cells convey a different viewpoint (that emodin being a prooxidant) and are presently holding an upper hand. It is appropriate to speculate the expansion-ROS generation by emodin, considering the structural characteristics of emodin. It being a quinone and an effective electron acceptor is likely that emodin intracellularly interacts with molecular oxygen and generates superoxide anion (39) . There are several recent studies showing the ability of emodin to generate ROS in a variety of tumor cells (40 -45) . However, reason for the earlier report of emodin not generating ROS in HL-60 leukemic cells is not clear (46) . But it is a known fact that most prooxidants/antioxidants behave differently depending on the experimental conditions and is possible that such phenomenon works true for emodin as well. This may also reflect more when cell lines of different tissue origin are used for analysis; it is known that cells vary with respect to their antioxidant status.
As we know, DNA still remains an attractive target for the design of antitumor agents (47) . Anthracyclines belong to the most useful antitumor drugs ever developed and the mechanism of intercalating to DNA has been studied extensively. Epirubicin, a type of anthracyclines, exerts its antitumor effect by intercalating to DNA. Anthraquinone derivative also contained anthracycline. To clarify whether AMAD showed cytotoxicity to MDA-MB-453 and Calu-3 cells via DNA-targeted pathway, we carried out the DNAbinding assay. In this study, epirubicin could compete with EB, a well-known DNA intercalator, to intercalate to DNA and the decreases of DNA bands fluorescence intensity exposed to epirubicin were observed. However, there were no dramatic differences of the DNA band fluorescence intensity between treatment with AMAD and the control (Fig. 3) . The results showed that AMAD-induced apoptosis might not involve intercalating to DNA.
In summary, AMAD was a potent cytotoxic agent to MDA-MB-453 and Calu-3 cells. Cross-talk between the caspase-8/Bid pathway and the mitochondrial pathway may exist in AMAD-induced apoptosis. Moreover, the mitochondrial pathway was independent of generation of ROS. DNA-binding assay implied that intercalating to DNA was not involved in apoptosis induced by AMAD. Our results revealed that AMAD may be a promising compound opening better anticancer treatment options.
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